Skip to content

Erasca, Inc. ERAS Short-Term Investments

Short-Term Investments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
Pfizer logo
PfizerPFE
$11.37B-28.4%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$1.47B-17.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$222.01M+40.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$513.68M-8.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$621M-22.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s short-term investments?
Erasca, Inc. (ERAS) reported short-term investments of $196.53M in Q1 2026.
How has Erasca, Inc.'s short-term investments changed year-over-year?
Erasca, Inc.'s short-term investments decreased by 16.0% year-over-year, from $234.1M to $196.53M.
What is the long-term trend for Erasca, Inc.'s short-term investments?
Over 5 years (2020 to 2025), Erasca, Inc.'s short-term investments has grown at a 30.6% compound annual growth rate (CAGR), from $53.33M to $202.27M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.